Production & Manufacturing

Chime Biologics and Daewoong Pharmaceutical have entered into a strategic collaboration to develop and manufacture a dupilumab biosimilar candidate referencing Dupixent for global markets. The partnership, announced by VMS Group, combines the development and manufacturing capabilities of Chime Biologics...

Contract research, development, and manufacturing organization (CRDMO) Aragen has announced the successful production of the first commercial-scale GMP batches of Daretabart (hu1418K322A), the lead therapeutic candidate of UK-based Renaissance Pharma Limited. The milestone marks a key step forward in...

Aragen, a global leader in Contract Research, Development, and Manufacturing Organization (CRDMO) services, has announced the successful technology transfer and commercial-scale GMP manufacturing of the first batches of Daretabart, Renaissance Pharma’s lead therapeutic candidate for high-risk neuroblastoma. The milestone...

CordenPharma, a global contract development and manufacturing organization specializing in complex drug modalities, has officially entered into an agreement to acquire AmbioPharm. The AmbioPharm Deal strengthens the company’s manufacturing presence in the United States while adding newly integrated production...

In a critical step for Colombia vaccine localization, SK Bioscience will execute a vaccine technology transfer with Colombia’s state-owned pharmaceutical enterprise, VECOL. The partnership focuses on building a local manufacturing site to align with the country's national vaccine localization...

Selecting the right laboratory equipment is a critical decision that directly impacts the efficiency, accuracy, and compliance of pharmaceutical operations. Evaluating analytical instruments pharma QC requirements involves a deep dive into technical specifications, vendor reliability, and the potential for long-term scalability. By choosing tools that integrate seamlessly with existing digital workflows and international regulatory standards, laboratory managers can ensure that their facility is equipped to handle the rigorous demands of modern drug testing and quality assurance. This strategic approach minimizes operational risk and ensures the delivery of safe and effective medications to patients globally.

Precision in pharmaceutical analysis is fundamental to ensuring that every therapeutic agent delivered to a patient meets the highest safety and efficacy standards. The implementation of high-grade spectrophotometers drug quality control workflows provides a scientific basis for quantifying chemical properties and physical characteristics with unmatched reliability. By leveraging advanced spectral data, manufacturers can validate formulations and detect impurities early in the production cycle, thereby reinforcing the integrity of the global supply chain, ensuring regulatory compliance, and protecting the well-being of patients around the world.